Home
>
National Drug Code (NDC)
>
VFEND
VFEND - 0049-3180-30 - (VORICONAZOLE)
Drug Information of VFEND
| Product NDC: | 0049-3180 |
| Proprietary Name: | VFEND |
| Non Proprietary Name: | VORICONAZOLE |
| Active Ingredient(s): | 200 mg/1 & nbsp; VORICONAZOLE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of VFEND
| Product NDC: | 0049-3180 |
| Labeler Name: | Roerig |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021266 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20030328 |
Package Information of VFEND
| Package NDC: | 0049-3180-30 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (0049-3180-30) |
NDC Information of VFEND
| NDC Code | 0049-3180-30 |
| Proprietary Name | VFEND |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (0049-3180-30) |
| Product NDC | 0049-3180 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | VORICONAZOLE |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20030328 |
| Marketing Category Name | NDA |
| Labeler Name | Roerig |
| Substance Name | VORICONAZOLE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |
